2020
DOI: 10.1111/1471-0528.16370
|View full text |Cite
|
Sign up to set email alerts
|

Re: Effect of progestogen for women with threatened miscarriage: a systematic review and meta‐analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2020
2020
2021
2021

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 6 publications
0
1
0
1
Order By: Relevance
“…Nowadays, micronized progesterone products are largely preferred and used in obstetrics (and not only in this field) for many medical conditions, including threatened miscarriage, recurrent pregnancy loss and PTB prevention [ 26 , 33 , 34 ]. Based on the major part of consistent researches, the vaginal administration would be the best option to use due to the better concentrations that reach the uterus for the “first uterine pass effect” and to avoid the unwanted side effects such as nausea, headache, and sleepiness derived from oral route [ 26 , 35 ].…”
Section: Progesterone: Biochemical “Identikit” and Rationale For Usementioning
confidence: 99%
“…Nowadays, micronized progesterone products are largely preferred and used in obstetrics (and not only in this field) for many medical conditions, including threatened miscarriage, recurrent pregnancy loss and PTB prevention [ 26 , 33 , 34 ]. Based on the major part of consistent researches, the vaginal administration would be the best option to use due to the better concentrations that reach the uterus for the “first uterine pass effect” and to avoid the unwanted side effects such as nausea, headache, and sleepiness derived from oral route [ 26 , 35 ].…”
Section: Progesterone: Biochemical “Identikit” and Rationale For Usementioning
confidence: 99%
“…У цій роботі автори об'єднали 10 досліджень, що вивчали різні прогестагени, природний прогестерон та синтетичні прогестини з різними шляхами введення (наприклад, пер оральний дидрогестерон і вагінальний прогестерон). Варто зазначити, що кілька важливих обмежень і слабких сторін цього дослідження були чітко визначені самими авторами, і про них краще було б повідомити заздалегідь у рефераті, як підкреслювали Жан Карло Ді Ренцо та Едуардо Фонсека [7]. Дійсно, у висновках, зазначених у рефераті, навіть не йдеться про оцінку ризику упередженості.…”
Section: про якість метааналізівunclassified